GSK Lobs False Ad Suit At Teva Over Axed Wellbutrin Generic
By Jeff Overley ( February 11, 2013, 1:19 PM EST) -- GlaxoSmithKline LLC on Friday launched a false advertising suit in Pennsylvania federal court accusing Teva Pharmaceuticals USA Inc. of costing it hundreds of millions of dollars by promoting a generic version of antidepressant Wellbutrin that was discontinued after its effectiveness came into question....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.